INNOVATION
Phase 2 Completed
172 enrolled
METEORA-II
Phase 2 Completed
140 enrolled 11 charts
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
MINDACT
Phase 3 Completed
6,600 enrolled
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
Phase 3 Completed
377 enrolled
CONTROL NETS
Phase 2 Completed
75 enrolled
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
Phase 2 Completed
45 enrolled 15 charts
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
Phase 2 Completed
146 enrolled 23 charts
Stop&Go
Phase 3 Completed
420 enrolled
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
Phase 2 Completed
79 enrolled 12 charts
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
Phase 2 Completed
83 enrolled 8 charts
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
Phase 2 Completed
105 enrolled 13 charts
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
Phase 2 Completed
57 enrolled 9 charts
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
Phase 2 Completed
21 enrolled
PETACC-6
Phase 3 Completed
1,094 enrolled
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
Phase 1 Completed
8 enrolled
Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
9 enrolled
Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy
Phase 2 Completed
25 enrolled
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
Phase 2 Completed
60 enrolled
S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
Phase 2 Completed
112 enrolled 6 charts
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Phase 2 Completed
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
Phase 1 Completed
24 enrolled
ELECT
Phase 2 Completed
35 enrolled
S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
Phase 2 Completed
29 enrolled
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
Phase 2 Completed
43 enrolled
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
86 enrolled
Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
Phase 1 Completed
15 enrolled
Preoperative Chemoradiation With Capecitabine and Cetuximab
Phase 2 Completed
31 enrolled
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Phase 3 Completed
536 enrolled
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Phase 2/3 Completed
333 enrolled